Fan Ying-Xin, Wong Lily, Deb Tushar B, Johnson Gibbes R
Division of Therapeutic Proteins, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA.
J Biol Chem. 2004 Sep 10;279(37):38143-50. doi: 10.1074/jbc.M405760200. Epub 2004 Jul 1.
The epidermal growth factor receptor (EGFR) kinase catalyzes phosphorylation of tyrosines in its C terminus and in other cellular targets upon epidermal growth factor (EGF) stimulation. Here, by using peptides derived from EGFR autophosphorylation sites and cellular substrates, we tested the hypothesis that ligand may function to regulate EGFR kinase specificity by modulating the binding affinity of peptide sequences to the active site. Measurement of the steady-state kinetic parameters, K(m) and k(cat), revealed that EGF did not affect the binding of EGFR peptides but increased the binding affinity for peptides corresponding to the major EGFR-mediated phosphorylation sites of the adaptor proteins Gab1 (Tyr-627) and Shc (Tyr-317), and for peptides containing the previously identified optimal EGFR kinase substrate sequence EEEEYFELV (3-7-fold). Conversely, EGF stimulation increased k(cat) approximately 5-fold for all peptides. Thus, ligand changed the relative preference of the EGFR kinase for substrates as evidenced by EGF increases of approximately 5-fold in the specificity constants (k(cat)/K(m)) for EGFR peptides, whereas approximately 15-40-fold increases were observed for other peptides, such as Gab1 Tyr-627. Furthermore, we demonstrate that EGF (i) increased the binding affinity of EGFR to Gab1 Tyr-627 and Shc Tyr-317 sites in purified GST fusion proteins approximately 4-6-fold, and (ii) EGF significantly enhanced the phosphorylation of these sites, relative to EGFR autophosphorylation, in cell lysates containing the full-length Gab1 and Shc proteins. Analysis of peptides containing amino acid substitutions indicated that residues C-terminal to the target tyrosine were critical for EGF-stimulated increases in substrate binding and regulation of kinase specificity. To our knowledge, this represents the first demonstration that ligand can alter specificity of a receptor kinase toward physiologically relevant targets.
表皮生长因子受体(EGFR)激酶在表皮生长因子(EGF)刺激下催化其C末端及其他细胞靶点中酪氨酸的磷酸化。在此,我们利用源自EGFR自身磷酸化位点和细胞底物的肽段,检验了配体可能通过调节肽段序列与活性位点的结合亲和力来调控EGFR激酶特异性的假说。对稳态动力学参数K(m)和k(cat)的测量表明,EGF不影响EGFR肽段的结合,但增加了对与衔接蛋白Gab1(酪氨酸-627)和Shc(酪氨酸-317)的主要EGFR介导的磷酸化位点相对应的肽段,以及对含有先前确定的最佳EGFR激酶底物序列EEEEYFELV的肽段的结合亲和力(3至7倍)。相反,EGF刺激使所有肽段的k(cat)增加了约5倍。因此,配体改变了EGFR激酶对底物的相对偏好,如EGF使EGFR肽段的特异性常数(k(cat)/K(m))增加约5倍所证明的那样,而其他肽段,如Gab1酪氨酸-627,则观察到约15至40倍的增加。此外,我们证明,EGF(i)使纯化的GST融合蛋白中EGFR与Gab1酪氨酸-627和Shc酪氨酸-317位点的结合亲和力增加了约4至6倍,并且(ii)相对于EGFR自身磷酸化,EGF在含有全长Gab1和Shc蛋白的细胞裂解物中显著增强了这些位点的磷酸化。对含有氨基酸取代的肽段的分析表明,靶酪氨酸C末端的残基对于EGF刺激的底物结合增加和激酶特异性调节至关重要。据我们所知,这是首次证明配体可改变受体激酶对生理相关靶点的特异性。